van Rooij Jeroen, Engel Angela, Remeijer Lies, van Cleijnenbreugel Hugo, Wubbels René
The Rotterdam Eye Hospital, Rotterdam, Netherlands.
Rotterdam Ophthalmic Institute, Rotterdam, Netherlands.
J Ophthalmol. 2018 Mar 11;2018:7320816. doi: 10.1155/2018/7320816. eCollection 2018.
To investigate the long-term anatomical and functional outcomes of Descemet stripping automated endothelial keratoplasty (DSAEK).
Prospective follow-up of 114 eyes (95 subjects) after DSAEK for endothelial dysfunction. Measurements included best spectacle-corrected visual acuity (BSCVA), straylight, endothelial cell density (ECD), and graft thickness.
The mean follow-up time was 5.1 ± 1.5 years. Four grafts ultimately failed (after 5 to 7 years). From baseline up to 1 year after DSAEK, mean BSCVA improved by 0.30 logMAR. This beneficial effect remained until the last follow-up (LFU). After DSAEK, straylight was reduced. ECD sharply dropped by 900 cells/mm (33%) immediately after surgery and, thereafter, steadily decreased at a rate of 11 cells/mm per month. No significant correlation was observed between graft thickness at 3 years and BSCVA.
We observed a low graft failure rate and a normalization of graft thickness. Postoperative straylight remained elevated relative to the normal population. The sharp initial and the subsequent more gradual ECD decline are consistent with other studies. A significant and prolonged functional gain can be achieved by posterior lamellar grafting for endothelial dysfunction.
探讨深板层角膜内皮移植术(DSAEK)的长期解剖学和功能学转归。
对114只眼(95例患者)行DSAEK治疗内皮功能障碍后进行前瞻性随访。测量指标包括最佳矫正视力(BSCVA)、散射光、内皮细胞密度(ECD)和植片厚度。
平均随访时间为5.1±1.5年。4枚植片最终失败(5至7年后)。从基线至DSAEK术后1年,平均BSCVA提高了0.30 logMAR。这一有益效果持续至最后一次随访(LFU)。DSAEK术后,散射光降低。术后ECD立即急剧下降900个细胞/mm²(33%),此后每月以11个细胞/mm²的速率稳步下降。3年时的植片厚度与BSCVA之间未观察到显著相关性。
我们观察到植片失败率较低且植片厚度恢复正常。术后散射光相对于正常人群仍处于较高水平。ECD最初的急剧下降及随后更缓慢的下降与其他研究一致。对于内皮功能障碍,通过后板层移植可实现显著且持久的功能改善。